Additionally, IL-4 and IL-13 from group 2 innate lymphoid cells suppressed antitumor immunity in a colorectal cancer model [47], and the production of IL-13 by group 2 innate lymphoid cells was upregulated by melanoma cells in vitro [48]. This evidence concerns the gene IL13 and colorectal cancer.